Souvien Therapeutics Company

Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.


Technology: Anti-infective Drugs
Industry: Biotechnology, Pharmaceutical
Headquarters: Salt Lake City, Utah, United States
Investors Number: 1
Total Funding: 3500000
Estimated Revenue: $10M to $50M
Last Funding Date: 2019
Last Funding Type: Venture - Series Unknown

Register and Claim Ownership